Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
GlycoNAVI Proteins
GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
| Source | Last Updated |
|---|---|
| GlycoNAVI Proteins | September 04, 2024 |
| PDB ID | UniProt ID | Title ▲ | Descriptor |
|---|---|---|---|
| 7OAO | 7OAO | Nanobody C5 bound to RBD | |
| 7OAN | P0DTC2 | Nanobody C5 bound to Spike | |
| 7OAN | 7OAN | Nanobody C5 bound to Spike | |
| 7B14 | P0DTC2 | Nanobody E bound to Spike-RBD in a localized reconstruction | |
| 7B14 | 7B14 | Nanobody E bound to Spike-RBD in a localized reconstruction | |
| 7OM4 | P00533 | Nanobody EgB4 bound to the full extracellular EGFR-EGF complex | |
| 7OM4 | 7OM4 | Nanobody EgB4 bound to the full extracellular EGFR-EGF complex | |
| 7OM4 | P01133 | Nanobody EgB4 bound to the full extracellular EGFR-EGF complex | |
| 7OAY | P0DTC2 | Nanobody F2 bound to RBD | |
| 7OAY | 7OAY | Nanobody F2 bound to RBD | |
| 7Z1A | P0DTC2 | Nanobody H11 and F2 bound to RBD | |
| 7Z1A | 7Z1A | Nanobody H11 and F2 bound to RBD | |
| 7Z1B | P0DTC2 | Nanobody H11-A10 and F2 bound to RBD | |
| 7Z1B | 7Z1B | Nanobody H11-A10 and F2 bound to RBD | |
| 7Z1C | P0DTC2 | Nanobody H11-B5 and H11-F2 bound to RBD | |
| 7Z1C | 7Z1C | Nanobody H11-B5 and H11-F2 bound to RBD | |
| 7Z1E | P0DTC2 | Nanobody H11-H4 Q98R H100E bound to RBD | |
| 7Z1E | 7Z1E | Nanobody H11-H4 Q98R H100E bound to RBD | |
| 7Z1D | P0DTC2 | Nanobody H11-H6 bound to RBD | |
| 7Z1D | 7Z1D | Nanobody H11-H6 bound to RBD | |
| 7OAP | 7OAP | Nanobody H3 AND C1 bound to RBD | |
| 7OAP | P0DTC2 | Nanobody H3 AND C1 bound to RBD | |
| 7OAQ | 7OAQ | Nanobody H3 AND C1 bound to RBD with Kent mutation | |
| 7OAQ | P0DTC2 | Nanobody H3 AND C1 bound to RBD with Kent mutation | |
| 4KRM | P00533 | Nanobody/VHH domain 7D12 in complex with domain III of the extracellular region of EGFR, pH 3.5 | |
| 4KRM | 4KRM | Nanobody/VHH domain 7D12 in complex with domain III of the extracellular region of EGFR, pH 3.5 | |
| 4KRL | P00533 | Nanobody/VHH domain 7D12 in complex with domain III of the extracellular region of EGFR, pH 6.0 | |
| 4KRL | 4KRL | Nanobody/VHH domain 7D12 in complex with domain III of the extracellular region of EGFR, pH 6.0 | |
| 4KRP | P00533 | Nanobody/VHH domain 9G8 in complex with the extracellular region of EGFR | |
| 4KRP | 4KRP | Nanobody/VHH domain 9G8 in complex with the extracellular region of EGFR | |
| 4KRO | P00533 | Nanobody/VHH domain EgA1 in complex with the extracellular region of EGFR | |
| 4KRO | 4KRO | Nanobody/VHH domain EgA1 in complex with the extracellular region of EGFR | |
| 6VPX | 6VPX | Nanodisc of full-length HIV-1 Envelope glycoprotein clone AMC011 in complex with one PGT151 Fab and three 10E8 Fabs | Envelope glycoprotein gp120, Envelope glycoprotein gp41, Antibody 10E8 Fab heavy chain, Antibody 10E8 Fab light chain, MPER peptide, Antibody PGT151 Fab heavy chain, Antibody PGT151 Fab light chain |
| 6QEE | 6QEE | Nanodisc reconstituted Human-mouse chimeric ABCB1 (ABCB1HM)-EQ mutant in complex with UIC2 Fab and Zosuquidar. | ABCB1HM-EQ, UIC2 Antigen Binding Fragment Light chain, UIC2 Antigen Binding Fragment Heavy Chain |
| 6QEX | P08183 | Nanodisc reconstituted human ABCB1 in complex with UIC2 fab and taxol | Multidrug resistance protein 1 (E.C.7.6.2.2), UIC2 Fab lightchain, UIC2 Fab heavy chain |
| 6QEX | 6QEX | Nanodisc reconstituted human ABCB1 in complex with UIC2 fab and taxol | Multidrug resistance protein 1 (E.C.7.6.2.2), UIC2 Fab lightchain, UIC2 Fab heavy chain |
| 7E9T | P0DTC2 | Nanometer resolution in situ structure of SARS-CoV-2 post-fusion spike | |
| 1W1O | Q9T0N8 | Native Cytokinin Dehydrogenase | CYTOKININ DEHYDROGENASE 1 (E.C.1.5.99.12) |
| 2GBC | P14740 | Native DPP-IV (CD26) from Rat | Dipeptidyl peptidase 4, EC 3.4.14.5, Dipeptidyl peptidase IV, DPP IV, T-cell activation antigen CD26, GP110 glycoprotein, Bile canaliculus domain-specific membrane glycoprotein, Contains: Dipeptidyl peptidase 4 membrane form (Dipeptidyl peptidase IV membrane form); Dipeptidyl peptidase 4 soluble form (Dipeptidyl peptidase IV soluble form); Dipeptidyl peptidase 4 60 kDa soluble form (Dipeptidyl peptidase IV 60 kDa soluble form) |
| 6UTO | A0A0U4BD45 | Native E. coli Glyceraldehyde 3-phosphate dehydrogenase | Glyceraldehyde-3-phosphate dehydrogenase (E.C.1.2.1.-) |
| 6UTN | A0A0U4BD45 | Native E. coli Glyceraldehyde 3-phosphate dehydrogenase | Glyceraldehyde-3-phosphate dehydrogenase (E.C.1.2.1.-) |
| 8FOI | P62812 | Native GABA-A receptor from the mouse brain, alpha1-beta2-gamma2 subtype, in complex with GABA and allopregnanolone | |
| 8FOI | P63137 | Native GABA-A receptor from the mouse brain, alpha1-beta2-gamma2 subtype, in complex with GABA and allopregnanolone | |
| 8FOI | P22723 | Native GABA-A receptor from the mouse brain, alpha1-beta2-gamma2 subtype, in complex with GABA and allopregnanolone | |
| 8FOI | 8FOI | Native GABA-A receptor from the mouse brain, alpha1-beta2-gamma2 subtype, in complex with GABA and allopregnanolone | |
| 8G4N | P62812 | Native GABA-A receptor from the mouse brain, alpha1-beta2-gamma2 subtype, in complex with GABA, Zolpidem, and endogenous neurosteroids | |
| 8G4N | P63137 | Native GABA-A receptor from the mouse brain, alpha1-beta2-gamma2 subtype, in complex with GABA, Zolpidem, and endogenous neurosteroids | |
| 8G4N | P22723 | Native GABA-A receptor from the mouse brain, alpha1-beta2-gamma2 subtype, in complex with GABA, Zolpidem, and endogenous neurosteroids | |
| 8G4N | 8G4N | Native GABA-A receptor from the mouse brain, alpha1-beta2-gamma2 subtype, in complex with GABA, Zolpidem, and endogenous neurosteroids | |
| 8G4O | P62812 | Native GABA-A receptor from the mouse brain, alpha1-beta2-gamma2 subtype, in complex with didesethylflurazepam and endogenous GABA |
